NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/02/2026
Voltar para busca
Dado oficial do USPTO
MOLECULIGHT DX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MOLECULIGHT DX
ST13
US500000090322952Classe
1, 9, 42
Pedido
90322952
Registro
8122800
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
87
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 9, 42
Data de depósito
16/11/2020
Data de registro
03/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/02/2026
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Toronto, ON, CA
Examinador
BURKE, JUSTINE N
Unidade examinadora
N30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
MolecuLight Inc.
Representantes
Janice Housey Litmus Law PLLC
Classificação técnica
Classes Nice
Classe 1Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Assays for research purposesbioassays for optically analyzing biological and chemical constituents for scientific applications
Classe 9
Computer hardware for optically analyzing biological and chemical constituents for medical applications and scientific applications
Classe 42
Research and development in the field of bioassays for optically analyzing biological and chemical constituents for medical applications and scientific applications
Publicações
Histórico de despachos e eventos da marca no USPTO.
87 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/12/2025
PUBO
PUBLISHED FOR OPPOSITION
16/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
15/11/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/11/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
15/11/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/11/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/09/2025
GNRT
NON-FINAL ACTION E-MAILED
16/09/2025
CNRT
NON-FINAL ACTION WRITTEN
16/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/09/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
15/09/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
24/03/2025
GNSL
LETTER OF SUSPENSION E-MAILED
24/03/2025
CNSL
SUSPENSION LETTER WRITTEN
24/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/03/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/03/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
28/01/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
28/01/2025
CNSI
SUSPENSION INQUIRY WRITTEN
28/01/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
30/07/2024
GNSL
LETTER OF SUSPENSION E-MAILED
30/07/2024
CNSL
SUSPENSION LETTER WRITTEN
30/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/07/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
29/07/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/05/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/05/2024
CNSI
SUSPENSION INQUIRY WRITTEN
07/05/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/05/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/11/2023
GNSL
LETTER OF SUSPENSION E-MAILED
01/11/2023
CNSL
SUSPENSION LETTER WRITTEN
01/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30/10/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/09/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/09/2023
CNSI
SUSPENSION INQUIRY WRITTEN
11/09/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/03/2023
GNSL
LETTER OF SUSPENSION E-MAILED
13/03/2023
CNSL
SUSPENSION LETTER WRITTEN
13/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/03/2023
ALIE
ASSIGNED TO LIE
13/03/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/03/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/11/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/11/2022
CNSI
SUSPENSION INQUIRY WRITTEN
03/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/05/2022
GNSL
LETTER OF SUSPENSION E-MAILED
05/05/2022
CNSL
SUSPENSION LETTER WRITTEN
05/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2022
ALIE
ASSIGNED TO LIE
29/04/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/04/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
18/11/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
18/11/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
18/11/2021
CNSI
SUSPENSION INQUIRY WRITTEN
18/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/06/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
18/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
18/05/2021
CNSL
SUSPENSION LETTER WRITTEN
18/05/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
18/05/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
18/05/2021
CNSI
SUSPENSION INQUIRY WRITTEN
18/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/05/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/05/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/05/2021
GNRT
NON-FINAL ACTION E-MAILED
03/05/2021
CNRT
NON-FINAL ACTION WRITTEN
03/05/2021
DOCK
ASSIGNED TO EXAMINER
26/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/01/2021
NWAP
NEW APPLICATION ENTERED
19/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOLECULIGHT DX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.